Are genome-edited micro-organisms covered by Directive 2009/41/EC?-implications of the CJEU's judgment in the case C-528/16 for the contained use of genome-edited micro-organisms [0.03%]
关于基因编辑微生物的《欧盟指令》(2009/41 / EC)适用问题-“C-528/16”案件对基因工程微生物实验活动的影响
Hans-Georg Dederer,David Hamburger
Hans-Georg Dederer
In its judgement of July 25, 2018, the Court of Justice of the European Union (CJEU) in the case C-528/16, Confédération paysanne and Others, held that organisms obtained by techniques of mutagenesis are 'genetically modified organisms' (...
Designing COVID-19 vaccine mandates in colleges and universities: a roadmap to the 10 key questions [0.03%]
高校和大学COVID-19疫苗接种强制令的设计：通往十个关键问题的路线图
Susan M Wolf,James G Hodge Jr
Susan M Wolf
COVID-19 transmission among students, faculty, and staff at US institutions of higher education (IHEs) is a pressing concern, especially with the dominance of the highly contagious Delta variant and emergence of the Omicron variant. From th...
The health equity mandate [0.03%]
卫生公平使命宣言
Wendy Netter Epstein
Wendy Netter Epstein
People of color and the poor die younger than the White and prosperous. And when they are alive, they are sicker. Health inequity is morally tragic. But it is also economically inefficient, raising the nation's healthcare bill and lowering ...
Governing through imaginaries: on the place and role of constructions of Japan within UK policy discourse regarding science, technology, and innovation [0.03%]
通过想象进行治理：日本构建在英国关于科学、技术与创新政策话语中的地位和作用
Martyn Pickersgill
Martyn Pickersgill
This article employs the notion of 'sociotechnical imaginaries' from the discipline of science and technology studies in order to consider the role that constructions of Japan play within UK policy discourse on science, technology, and inno...
Prospect patents and CRISPR; rivalry and ethical licensing in a semi-commons environment [0.03%]
CRISPR的预期专利；半共有环境中的竞争和道德许可问题
Andreas Panagopoulos,Katerina Sideri
Andreas Panagopoulos
The prospect theory of patents views patents as a tool for the development and commercialization of inventions. Prospect patents rely on broad control of technology so that rivalry between competing products is diminished thus avoiding wast...
Demystifying Schrems II for the cross-border transfer of clinical research data [0.03%]
Schrems II揭秘——临床研究数据的跨境传输
Joseph Liss,David Peloquin,Mark Barnes et al.
Joseph Liss et al.
The Courts of Justice of the European Union (CJEU) held in its July 2020 Schrems II decision that, in order for entities in other countries to import personal data from the European Economic Area (EEA), the importer must be able to provide ...
An empirical study of large, human biobanks: intellectual property policies and financial conditions for access [0.03%]
大型人类生物银行的经验研究：访问的知识共享政策和财政条件
Matthew Jordan,Johnathon Liddicoat,Kathleen Liddell
Matthew Jordan
Biobanks are repositories that collect, store and distribute large quantities of biological samples and associated data (collectively called biobank `material'). Although biobanks have different modes of operation, all face a variety of sim...
Kathleen Liddell,David A Simon,Anneke Lucassen
Kathleen Liddell
This article answers two questions from the perspective of United Kingdom law and policy: (i) is health information property? and (ii) should it be? We argue that special features of health information make it unsuitable for conferral of pr...
Julia Mosquera
Julia Mosquera
Katharina Ó Cathaoir
Katharina Ó Cathaoir
This article seeks to bring the invisible child of personalized medicine out from the shadows through legal analysis and empirical data. It uses Denmark as a case to argue that existing policies, laws and practices on personalized medicine ...